These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8250077)

  • 1. Relative letter and position difficulty on visual acuity charts from the Early Treatment Diabetic Retinopathy Study.
    Ferris FL; Freidlin V; Kassoff A; Green SB; Milton RC
    Am J Ophthalmol; 1993 Dec; 116(6):735-40. PubMed ID: 8250077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of visual acuity charts in young adults and patients with diabetic retinopathy.
    Plainis S; Kontadakis G; Feloni E; Giannakopoulou T; Tsilimbaris MK; Pallikaris IG; Moschandreas J
    Optom Vis Sci; 2013 Feb; 90(2):174-8. PubMed ID: 23314130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an Automated Early Treatment Diabetic Retinopathy Study Low-contrast Letter Acuity Test.
    Pang Y; Sparschu L; Nylin E; Wang J
    Optom Vis Sci; 2020 May; 97(5):370-376. PubMed ID: 32413009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified ETDRS visual acuity chart for European-wide use.
    Plainis S; Tzatzala P; Orphanos Y; Tsilimbaris MK
    Optom Vis Sci; 2007 Jul; 84(7):647-53. PubMed ID: 17632314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the legibility of letters at contrast threshold using the Pelli-Robson chart.
    Elliott DB; Whitaker D; Bonette L
    Ophthalmic Physiol Opt; 1990 Oct; 10(4):323-6. PubMed ID: 2263364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old.
    Cotter SA; Chu RH; Chandler DL; Beck RW; Holmes JM; Rice ML; Hertle RW; Birch EE; Moke PS
    Am J Ophthalmol; 2003 Oct; 136(4):655-61. PubMed ID: 14516805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should 30 letters be added to the 4 m visual acuity score on the Early Treatment Diabetic Retinopathy Study Chart?
    Chen FK; Ah-See KL; Wong EN; Tang I
    Clin Exp Ophthalmol; 2016 May; 44(4):355-6. PubMed ID: 26856543
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative legibility and confusions of letter acuity targets in the peripheral and central retina.
    Reich LN; Bedell HE
    Optom Vis Sci; 2000 May; 77(5):270-5. PubMed ID: 10831217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of response biases on resolution thresholds of Sloan letters in central and paracentral vision.
    Barhoom H; Joshi MR; Schmidtmann G
    Vision Res; 2021 Oct; 187():110-119. PubMed ID: 34252726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual acuity and contrast sensitivity for individual Sloan letters.
    Alexander KR; Xie W; Derlacki DJ
    Vision Res; 1997 Mar; 37(6):813-9. PubMed ID: 9156226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varying difficulty of Snellen letters and common errors in amblyopic and fellow eyes.
    Mathew JA; Shah SA; Simon JW
    Arch Ophthalmol; 2011 Feb; 129(2):184-7. PubMed ID: 21320964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-based measurement of letter and word acuity.
    Whatham AR; Mermoud C; Déruaz A; Goldschmidt M; Zesiger P; Safran AB
    Ophthalmic Physiol Opt; 2006 Mar; 26(2):156-68. PubMed ID: 16460316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Pocket Vision Screener and its effectiveness at screening visual acuity deficits.
    Raja M; Ramamurthy D; Srinivasan K; Varadharajan LS
    Indian J Ophthalmol; 2014 Dec; 62(12):1152-5. PubMed ID: 25579360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snellen chart may be preferable over early treatment diabetic retinopathy study charts for rapid visual acuity assessment.
    Tewari HK; Kori V; Sony P; Venkatesh P; Garg S
    Indian J Ophthalmol; 2006 Sep; 54(3):214. PubMed ID: 16921230
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
    Aiello LP; Vignati L; Sheetz MJ; Zhi X; Girach A; Davis MD; Wolka AM; Shahri N; Milton RC;
    Retina; 2011 Nov; 31(10):2084-94. PubMed ID: 21862954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of letter separation on computerised visual acuity measurements: comparison with the gold standard Early Treatment Diabetic Retinopathy Study (ETDRS) chart.
    Shah N; Laidlaw DA; Brown G; Robson C
    Ophthalmic Physiol Opt; 2010 Mar; 30(2):200-3. PubMed ID: 20444125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Acuity Testing Using a Random Method Visual Acuity Application.
    Rhiu S; Lee HJ; Goo YS; Cho K; Kim JH
    Telemed J E Health; 2016 Mar; 22(3):232-7. PubMed ID: 26280910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slope of psychometric functions and termination rule analysis for low contrast acuity charts.
    Carkeet A; Bailey IL
    Ophthalmic Physiol Opt; 2017 Mar; 37(2):118-127. PubMed ID: 28211180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual Letter Contrast Thresholds: Effect of Object Frequency and Noise.
    Hall C; Wang S; McAnany JJ
    Optom Vis Sci; 2015 Dec; 92(12):1125-32. PubMed ID: 26540471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early treatment in diabetic retinopathy study chart compared with the tumbling-E and Landolt-C.
    Treacy MP; Hurst TP; Conway M; Duignan ES; Dimitrov BD; Brennan N; Cassidy L
    Ophthalmology; 2015 May; 122(5):1062-3.e1. PubMed ID: 25582784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.